Efficacy and safety of propranolol in infants with heart failure due to moderate-to-large ventricular septal defect (VSD-PHF study) - A prospective randomized trial.

Ann Pediatr Cardiol · 2021 · PMC8457270 · PMID 34667404

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significanceP = 0.07so close (0.05 < p ≤ 0.1)

This difference did not reach statistical significance despite a trend toward improvement in the propranolol arm ( P = 0.07).

also in 111,027 other papers

a favorable trendno p-value reported

Although our study did not show any statistically significant benefit of propranolol therapy in the reduction of mortality, it showed a favorable trend by preventing worsening of HF symptoms and hospitalization.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.